thromboxanes has been researched along with Peripheral Arterial Disease in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Januszek, R; Maga, P; Mika, P; Niżankowski, R; Nowobilski, R | 1 |
| Bounameaux, H; Cairols, MA; Clement, DL; Coccheri, S; Fiessinger, JN; Fletcher, JP; Hoffmann, U; Turpie, AG | 1 |
| Aslam, M; Parmar, JH; Standfield, NJ | 1 |
1 trial(s) available for thromboxanes and Peripheral Arterial Disease
| Article | Year |
|---|---|
Thromboxane Antagonism with terutroban in Peripheral Arterial Disease: the TAIPAD study.
Topics: Adenosine Diphosphate; Adult; Aged; Aspirin; Blood Pressure; Double-Blind Method; Female; Humans; Male; Middle Aged; Naphthalenes; Peripheral Arterial Disease; Placebos; Platelet Aggregation; Propionates; Thromboxanes; Time Factors | 2010 |
2 other study(ies) available for thromboxanes and Peripheral Arterial Disease
| Article | Year |
|---|---|
The improvement of walking abilities and endothelial function after the supervised training treadmill program (STTP) in patients with peripheral artery disease (PAD) is not related to prostacyclin and thromboxane release.
Topics: Aged; Aged, 80 and over; Ankle Brachial Index; Biomarkers; Endothelium, Vascular; Epoprostenol; Exercise Test; Exercise Therapy; Female; Follow-Up Studies; Humans; Male; Middle Aged; Peripheral Arterial Disease; Prospective Studies; Thromboxanes; Treatment Outcome; Vasodilation; Walking | 2016 |
Significant prostacyclin/thromboxane level imbalance after lower limb arterial angioplasty: a possible platelet function alteration.
Topics: Adult; Aged; Aged, 80 and over; Angioplasty; Ankle Brachial Index; Biomarkers; Blood Platelets; Constriction, Pathologic; Dinoprost; England; Epoprostenol; Female; Femoral Artery; Humans; Iliac Artery; Lower Extremity; Male; Middle Aged; Peripheral Arterial Disease; Platelet Activation; Prostaglandins I; Radiography, Interventional; Thromboxane A2; Thromboxane B2; Thromboxanes; Time Factors; Treatment Outcome | 2010 |